A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if using a combination of other drug classes, like the
ones that Kaletra® and Intelence™ belong to, can still help reduce the amount of HIV in your
blood. Using Kaletra® and Intelence™ without other drugs is not approved by the FDA and so
their use in this study is experimental.